Cheng Sokleaph, Hide Mallorie, Pheng Sok Heng, Kerléguer Alexandra, Delvallez Gauthier, Sam Sophan, Mao Tan Eang, Nguyen Thi Van Anh, Bañuls Anne-Laure
Institut Pasteur du Cambodge and Ministry of Health, Phnom Penh, Cambodia.
Medical Biology Laboratory, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Infect Drug Resist. 2021 Mar 17;14:1089-1104. doi: 10.2147/IDR.S289907. eCollection 2021.
Due to the emergence of (M.tb) clinical isolates resistant to most potent first-line drugs (FLD), second-line drugs (SLD) are being prescribed more frequently. We explore the genetic characteristics and molecular mechanisms of M.tb isolates phenotypically resistant to SLD, including pre-extensively drug-resistant (pre-XDR) and extensively drug-resistant (XDR) isolates.
Drug-resistant (DR) M.tb isolates collected from 2012 to 2017 were tested using sequencing and phenotypic drug susceptibility testing. Genotypes were determined to explore their links with SLD resistance patterns.
Of the 272 DR M.tb isolates, 6 non-multidrug resistant (non-MDR) isolates were fluoroquinolones (FQ)-resistant, 3 were XDR and 16 were pre-XDR (14 resistant to FQ and 2 to second-line injectable drugs). The most frequent mutations in FQ-resistant and second-line injectable drugs resistant isolates were D94G (15/23) and a1401g (3/5), respectively. Seventy-five percent of pre-XDR isolates and 100% of XDR isolates harbored mutations conferring resistance to pyrazinamide. All XDR isolates belonged to the Beijing genotype, of which one, named XDR+, was resistant to all drugs tested. One cluster including pre-XDR and XDR isolates was observed.
This is the first description of SLD resistance in Cambodia. The data suggest that the proportion of XDR and pre-XDR isolates remains low but is on the rise compared to previous reports. The characterization of the XDR+ isolate in a patient who refused treatment underlines the risk of transmission in the population. In addition, genotypic results show, as expected, that the Beijing family is the main involved in pre-XDR and XDR isolates and that the spread of the Beijing pre-XDR strain is capable of evolving into XDR strain. This study strongly indicates the need for rapid interventions in terms of diagnostic and treatment to prevent the spread of the pre-XDR and XDR strains and the emergence of more resistant ones.
由于出现了对大多数强效一线药物(FLD)耐药的结核分枝杆菌(M.tb)临床分离株,二线药物(SLD)的处方频率越来越高。我们探讨了表型上对SLD耐药的M.tb分离株的遗传特征和分子机制,包括准广泛耐药(pre-XDR)和广泛耐药(XDR)分离株。
对2012年至2017年收集的耐药(DR)M.tb分离株进行测序和表型药物敏感性测试。确定基因型以探索它们与SLD耐药模式的联系。
在272株DR M.tb分离株中,6株非多重耐药(non-MDR)分离株对氟喹诺酮类(FQ)耐药,3株为XDR,16株为准XDR(14株对FQ耐药,2株对二线注射用药物耐药)。对FQ耐药和对二线注射用药物耐药的分离株中最常见的突变分别是D94G(15/23)和a1401g(3/5)。75%的准XDR分离株和100%的XDR分离株携带赋予对吡嗪酰胺耐药性的突变。所有XDR分离株均属于北京基因型,其中一株名为XDR+,对所有测试药物均耐药。观察到一个包括准XDR和XDR分离株的聚类。
这是柬埔寨首次对SLD耐药情况的描述。数据表明,XDR和准XDR分离株的比例仍然较低,但与之前的报告相比呈上升趋势。在一名拒绝治疗的患者中发现XDR+分离株凸显了人群中传播的风险。此外,基因型结果正如预期所示,北京家族是准XDR和XDR分离株的主要涉及对象,并且北京准XDR菌株的传播能够演变成XDR菌株。这项研究强烈表明需要在诊断和治疗方面迅速采取干预措施,以防止准XDR和XDR菌株的传播以及出现更多耐药菌株。